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Clostridium species are anaerobic Gram-positive rods that can cause a broad range of invasive infections in humans, including
myonecrosis and bacteremia. Importantly, clostridial bacteremia is frequently associated with underlying medical conditions, such
as colonicmalignancy. CharacterizingClostridium spp. and understanding their associated clinical disease spectrum are paramount
to provide optimal treatment, thereby decreasing morbidity and mortality especially in those with underlying debilitating
comorbidities. Clostridium paraputrificum is an infrequently isolated Clostridium species and its clinical significance has not been
well described. We herein report a case of bacteremia due to C. paraputrificum in a 65-year-old man with AIDS who developed
acute colonic necrosis complicated by septic shock. We then review other cases of bacteremia associated with C. paraputrificum in
the literature in addition to discussing the clinical significance of anaerobic bacteremia in general. To our knowledge, our report is
the second case of C. paraputrificum bacteremia in a patient with AIDS.
1. Introduction
Anaerobic bacteria are a major component of the human
microflora residing on mucous membranes. They can cause
a wide array of infectious diseases following the breakdown
of mucosal barriers at different anatomic sites. Among many
Clostridium species, Clostridium paraputrificum is an unfa-
miliar infrequent isolate; therefore its clinical significance has
not been well described. We report a case of bacteremia due
to C. paraputrificum in a patient with AIDS to characterize
the underlying disease spectrum as well as the clinical
importance of C. paraputrificum-related bacteremia.
2. Case Report
A 65-year-old man with a history of acquired human
immunodeficiency syndrome (AIDS) was in his usual status
until three days prior to presentation, when he suddenly
developed dizziness. He was seen in the emergency room
at a public hospital in Indianapolis, where he was found to
be persistently hypotensive. He was given intravenous fluid
resuscitation and was hospitalized for further investigation.
Human immunodeficiency virus (HIV) infection had been
diagnosed 19 years before. The CD4 T-lymphocytes cell
count at diagnosis was 525 cells per cubic millimeter, and
the HIV viral load was 4500 copies per milliliter. The
CD4 count one year to presentation was 248 per cubic
millimeter, and the HIV viral load was 150,000 copies per
milliliter. He had been noncompliant with his antiretroviral
agents since the diagnosis of HIV infection. He also had
a history of ischemic cardiomyopathy, atrial fibrillation,
chronic orthostatic hypotension, diabetes mellitus, hepatitis
B, hepatitis C, and end-stage renal disease for which he was
receiving hemodialysis. The patient was taking didanosine,
stavudine, and nevirapine for HIV intermittently. He was
not on antiretroviral therapy on admission. Two days after
admission, he developed severe abdominal pain followed by
massive hematochezia. He subsequently developed hemody-
namic instability which required the initiation of vasopressin
and norepinephrine. An abdominal radiograph showed small
bowel ileus and the colonic cutoff sign at the splenic flexure.
A computer tomography scan of the abdomen showed diffuse
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Figure 1: Gram stain of the blood culture showing Gram-positive
rods with spores.
colonicwall thickening.An emergent exploratory laparotomy
revealed extensive colitis with necrosis which necessitated
subtotal colectomy. On physical examination after surgery,
the patient appeared critically ill. The temperature was 99.5∘F
(37.5∘C), blood pressure 102/59mmHg, pulse 100 beats per
minute, respirations 25 breaths per minute, and oxygen
saturation 99%onFiO
2
of 40%.His heart soundswere regular
without murmurs and his lungs were clear to auscultation.
There was a large abdominal midline incision. The abdomen
was remarkably distended. There were three drainage tubes
with serosanguinous fluid inside. A right sided colostomywas
also in place. He had an arteriovenous fistula on the left arm.
The remainder of physical examination was unremarkable.
Laboratory studies revealed a white blood cell count
of 13,100 cells/mm3 with 12% band forms, hemoglobin of
8.0 g/dL, and platelets of 96,000 per cubic millimeter. Other
abnormal laboratory values included potassium 4.7mmol/L,
bicarbonate 18mEq/L, urea nitrogen 33mg/dL, creatinine
4.5mg/dL, aspartate aminotransferase 100U/L, total bilirubin
5.5mg/dL, and lactic acid 10.0mmol/L. The CD4 count was
10 per cubic millimeter, and the HIV viral load was 630,000
copies per milliliter. The patient was started on intravenous
vancomycin and piperacillin/tazobactam. Caspofungin was
added after colectomy. The patient remained in a critical
condition, requiring high doses of pressors. Three of four
sets of blood cultures obtained on admission turned positive
in anaerobic bottles. A gram stain of the blood cultures
showed Gram-positive rods with spores (Figure 1), which
were identified asClostridium paraputrificum by the available
automated identification system (VITEK 2) in our laboratory.
Tissue cultures of the necrotic ascending colon obtained dur-
ing the extensive colectomy also yielded C. paraputrificum.
Metronidazolewas added to the initial antibiotic regimen and
the patient demonstrated gradual clinical improvement. He
was weaned off mechanical ventilation and was transferred
to a rehabilitation facility on day 15 after admission.
3. Discussion
Anaerobes are a major component of the human microflora
residing on mucous membranes. Although anaerobes have
been increasingly recognized as important pathogens that
can cause a wide range of diseases following the breakdown
of mucosal barriers at different anatomic sites, studies have
reported conflicting data regarding the incidence of anaero-
bic bacteremia.
According to studies conducted in 1970s, the rate of
anaerobes in positive blood cultures was 26.3% in 1972 [1] and
21% during the period 1974–1978 at theMayo Clinic [2]. After
that, however, the rate of anaerobic bacteremia fell to 15%
during 1979–1983 and further down to 10% during 1984–1988
at the same institution [2]. In 1993, Peraino et al. investigated
7,397 blood cultures. 771 of the 7,397 blood cultures yielded
bacteria or fungi; 569 (7.7%) were true positive cultures, 35
(6.2%) of which yielded 48 anaerobic isolates [3]. Overall,
the rate of anaerobic bacteremia appeared decreased from the
1970s through the early 1990s.
Since 1993, however, the incidence of anaerobic bac-
teremia has increased in a large study conducted at the Mayo
Clinic. The mean annual incidence of anaerobic bacteremia
was 53 cases during 1993–1996, 75 cases during 1997–2000,
and 91 cases during 2001–2004, accounted for 74% increase in
the total number of cases of anaerobic bacteremia per 100,000
patient-days [4]. In the same study, Bacteroides species,
particularly B. fragilis, and Clostridium species were the most
frequent isolates.
Clostridium spp. are Gram-positive anaerobic rods that
are capable of producing endospores. Conventional classifi-
cation methods for Clostridium spp. rely on multiple micro-
biological and biochemical characteristics, including gram
stain morphology and carbohydrate fermentation profiles.
However, the development of gene sequencing techniques
made it possible to identify the genus Clostridium to the
species level. Woo et al. conducted a study over the period
1998–2001 where all cases of clostridium bacteremia were
prospectively studied and non-perfringens isolates were iden-
tified to the species level by 16S rRNA gene sequencing. 17
blood cultures were due to 11 non-Clostridium perfringens
species, of which four blood cultures yielded C. paraputrifi-
cum [5].
Clostridium spp. can cause a wide spectrum of severe
infections in humans, including myonecrosis, intraabdomi-
nal infections, and bacteremia. In a retrospective population-
based surveillance study conducted in Canada during the
period 2000–2006, 138 cases of bacteremia due toClostridium
spp. were found. C. perfringens was the most commonly
identified species with 58 (42%) isolates followed by C.
septicum (19 isolates; 14%) and C. ramosum (13 isolates; 9%).
Only 2 cases of bacteremia were caused by C. paraputrificum.
Significant risk factors associated with clostridial bacteremia
in this study included hemodialysis, malignancy, and inflam-
matory bowel disease [6]. Another study investigating risk
factors for mortality in patients with anaerobic bacteremia
demonstrated that the presence of liver disease and patient
age were the only significant risk factors in a multivariate
analysis [7].
As far as we know, case reports of bacteremia due to C.
paraputrificum are sporadic in the literature. The underlying
conditions associated with bacteremia due to C. paraputri-
ficum include noncyclic neutropenia [8], alcohol abuse [9],
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diabetes mellitus [10], sickle cell anemia [11], malignancy [12,
13], andAIDS [14]. To our knowledge, our report is the second
case of C. paraputrificum bacteremia reported in a patient
with AIDS. Importantly, isolation of certain Clostridium spp.,
such asC. septicum, may reflect the presence of an underlying
colonic malignancy. Horie et al. reported a deleterious effect
of C. paraputrificum on undesirable bile acid transformation,
which may be associated with an increased risk of colon
cancer [15]. Nevertheless, further studies are needed to
determine the association between C. paraputrificum and
colonic malignancy given the paucity of case reports and
studies on C. paraputrificum-associated bacteremia.
4. Conclusions
Clostridium spp. are one of the most commonly identified
isolates of anaerobic bacteremia. Although C. paraputrificum
is an infrequent isolate from blood cultures, a wide range
of underlying medical comorbidities have been described in
the literature. We reported a rare case of bacteremia with C.
paraputrificum in a patient with AIDSwho developed colonic
necrosis. Further studies are needed to elucidate the disease
spectrum, pathogenesis, and risk factors for C. paraputrifi-
cum-related invasive infections, including bacteremia.
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